Mr Ez Aldeen Esawi
Higher Degree by Research Candidate
School of Pharmacy and Biomedical Sciences
College of Health
| Date | Position | Institution name |
|---|---|---|
| 2019 - 2023 | Research assistance | University of Jordan |
| 2017 - 2023 | Medical laboratory technologist | King Hussein Cancer Center |
| Language | Competency |
|---|---|
| Arabic | Can read, write, speak, understand spoken and peer review |
| English | Can read, write, speak and understand spoken |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2018 - 2021 | University of Jordan | Jordan | M.Sc. Medical laboratory sciences |
| 2013 - 2017 | Hashemite University | Jordan | BSc |
| Year | Citation |
|---|---|
| 2025 | Mahmoud, I. S., Nsairat, H., Alsotari, S., Jaber, A., Esawi, E., Abdelnabi, H., . . . Odeh, F. (2025). Thymoquinone chemically conjugated to doxorubicin: antitumor activity and subcellular localization. RSC ADVANCES, 15(45), 38176-38188. |
| 2024 | Alkhawaja, B., Abuarqoub, D., Al-Natour, M., Alshaer, W., Abdallah, Q., Esawi, E., . . . Watts, A. G. (2024). Facile Rebridging Conjugation Approach to Attain Monoclonal Antibody-Targeted Nanoparticles with Enhanced Antigen Binding and Payload Delivery. Bioconjugate Chemistry, 35(10), 1491-1502. Scopus1 WoS1 |
| 2023 | Esawi, E. I., Mahmoud, I. S., Abdullah, M. S., Abuarqoub, D. A., Ahram, M. A., & Alshaer, W. M. (2023). 1,4-Naphthoquinone Induces FcRn Protein Expression and Albumin Recycling in Human THP-1 Cells. ACS Omega, 8(18), 16491-16499. Scopus4 WoS3 Europe PMC2 |
| 2023 | Abuarqoub, D., Mahmoud, N., Alshaer, W., Mohammad, M., Ibrahim, A. A., Al-Mrahleh, M., . . . Awidi, A. (2023). Biological Performance of Primary Dental Pulp Stem Cells Treated with Gold Nanoparticles. Biomedicines, 11(9), 1-15. Scopus2 WoS2 Europe PMC2 |
| 2023 | Niemi, M. E. K., Karjalainen, J., Liao, R. G., Neale, B. M., Daly, M., Ganna, A., . . . Sedaghati-Khayat, B. (2023). Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x). Nature, 621(7977), E7-E26. Scopus63 WoS77 Europe PMC74 |
| 2023 | Nsairat, H., Alshaer, W., Odeh, F., Esawi, E., Khater, D., Bawab, A. A., . . . Mubarak, M. S. (2023). Recent advances in using liposomes for delivery of nucleic acid-based therapeutics. Opennano, 11, 100132. Scopus86 |
| 2023 | Alshaer, W., Nsairat, H., Lafi, Z., Hourani, O. M., Al-Kadash, A., Esawi, E., & Alkilany, A. M. (2023). Quality by Design Approach in Liposomal Formulations: Robust Product Development. Molecules, 28(1), 19 pages. Scopus53 WoS45 Europe PMC27 |
| 2022 | Al-Azzawi, H., Alshaer, W., Esawi, E., Lafi, Z., Abuarqoub, D., Zaza, R., . . . Awidi, A. (2022). Multifunctional nanoparticles recruiting hyaluronic acid ligand and polyplexes containing low molecular weight protamine and ATP-Sensitive DNA motif for doxorubicin delivery. Journal of Drug Delivery Science and Technology, 69, 11 pages. Scopus10 WoS7 |
| 2022 | The COVID-19 Host Genetics Initiative., & Ganna, A. (2022). A second update on mapping the human genetic architecture of COVID-19. Europe PMC3 |
| 2021 | Sweidan, N., Esawi, E., Ismail, M., & Alshaer, W. (2021). Anticancer Cardenolides from the aerial parts of Calortopis procera. Zeitschrift Fur Naturforschung Section C Journal of Biosciences, 76(5), 243-250. Scopus4 WoS4 Europe PMC3 |
| 2021 | Mahmoud, I. S., Hatmal, M. M., Abuarqoub, D., Esawi, E., Zalloum, H., Wehaibi, S., . . . Alshaer, W. (2021). 1,4-Naphthoquinone Is a Potent Inhibitor of IRAK1 Kinases and the Production of Inflammatory Cytokines in THP-1 Differentiated Macrophages. ACS Omega, 6(39), 25299-25310. Scopus25 WoS22 Europe PMC15 |
| 2021 | Esawi, E., Alshaer, W., Mahmoud, I. S., Alqudah, D. A., Azab, B., & Awidi, A. (2021). Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells. International Journal of Molecular Sciences, 22(23), 12940. Scopus15 WoS16 Europe PMC10 |
| 2020 | Odeh, F., Nsairat, H., Alshaer, W., Ismail, M. A., Esawi, E., Qaqish, B., . . . Ismail, S. I. (2020). Aptamers chemistry: Chemical modifications and conjugation strategies. Molecules, 25(1), 51 pages. Scopus310 WoS285 Europe PMC208 |
| Year | Citation |
|---|---|
| 2022 | Esawi, E., Nsairat, H., Mahmoud, I. S., Lafi, Z., Al-Kadash, A., Al-Ragheb, B. A., . . . Alhaer, W. (2022). Clinical use and future perspective of aptamers. In Aptamers Engineered Nanocarriers for Cancer Therapy (pp. 481-520). Elsevier. DOI Scopus9 |
| 2022 | Nsairat, H., Alshaer, W., Mahmoud, I. S., Ismail, M. A., Esawi, E., Alsotari, S., & Ismail, S. I. (2022). Aptamers in Theranostic Bionanomaterials. In Bionanotechnology Next Generation Therapeutic Tools (pp. 130-158). BENTHAM SCIENCE PUBLISHERS. DOI Scopus1 |
Connect With Me
External Profiles
